Difference between revisions of "Adenocarcinoma of the urinary bladder"
Jump to navigation
Jump to search
(→IHC) |
|||
| Line 23: | Line 23: | ||
*CK7 +ve. | *CK7 +ve. | ||
*CK20 +ve. | *CK20 +ve. | ||
*CDX2 +ve (strong, diffuse). | |||
*Beta-catenin +ve (membranous, not nuclear). | |||
**[[Colorectal adenocarcinoma]] usu. has nuclear staining. | |||
*Thrombomodulin +ve/-ve (~60% of cases). | |||
**[[Colorectal adenocarcinoma]] -ve. | |||
**[[Urothelial carcinoma]] +ve (~90% of cases). | |||
==See also== | ==See also== | ||
Revision as of 12:16, 15 April 2014
Adenocarcinoma of the urinary bladder, also primary adenocarcinoma of the urinary bladder, is a very uncommon malignant bladder tumour.
General
- Very rare.[1]
Clinical:
- Like urothelial carcinoma - usu. hematuria.[1]
Microscopic
Features:
- Nuclear pleomorphism.
- Glandular differentiation.
- No urothelial differentiation - important.[2]
DDx:
- Urachal carcinoma - dome of bladder.
- Invasive urothelial carcinoma with glandular differentiation - has urothelial differentiation.
- Metastatic adenocarcinoma.
IHC
Features - variable:[3]
- CK7 +ve.
- CK20 +ve.
- CDX2 +ve (strong, diffuse).
- Beta-catenin +ve (membranous, not nuclear).
- Colorectal adenocarcinoma usu. has nuclear staining.
- Thrombomodulin +ve/-ve (~60% of cases).
- Colorectal adenocarcinoma -ve.
- Urothelial carcinoma +ve (~90% of cases).
See also
References
- ↑ 1.0 1.1 Ranadive, NU.; Trivedi, VD.; Gadgil, NM. (Oct 1999). "Primary adenocarcinoma of the urinary bladder: a study of 6 cases from the pathologist's point of view.". Arch Esp Urol 52 (8): 906-11. PMID 11762445.
- ↑ Zhong, M.; Gersbach, E.; Rohan, SM.; Yang, XJ. (Mar 2013). "Primary adenocarcinoma of the urinary bladder: differential diagnosis and clinical relevance.". Arch Pathol Lab Med 137 (3): 371-81. doi:10.5858/arpa.2012-0076-RA. PMID 23451748.
- ↑ Roy, S.; Parwani, AV. (Dec 2011). "Adenocarcinoma of the urinary bladder.". Arch Pathol Lab Med 135 (12): 1601-5. doi:10.5858/arpa.2009-0713-RS. PMID 22129192.